Skip to content

Comparison of Bidirectional Palpation Test and Transit Time Flow Measurement for LIMA-LAD Graft Patency

Comparison of Bidirectional Palpation Test and Transit Time Flow Measurement for LIMA-LAD Graft Patency

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06934993
Enrollment
116
Registered
2025-04-18
Start date
2023-08-31
Completion date
2024-09-14
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arterial Disease (CAD), Coronary Artery Bypass, Graft Patency, LAD (Left Anterior Descending) Coronary Artery Stenosis, LIMA, LIMA GREFT PATENCY, LIMA-LAD ANASTOMOSIS, Saphenous Vein Graft Patency

Keywords

GRAFT PATENCY, LIMA-LAD ANATOMOSIS, LIMA GRAFT PATENCY, SAPHENOUS VEİN GRAFT PATENCY, CABG

Brief summary

The most important factor determining mortality and morbidity after coronary artery bypass graft (CABG) surgery is graft patency. The LIMA-LAD anastomosis is the most crucial anastomosis because it's revascularizing the most important and large region of the heart, has superior long-term graft patency rates and is considered the gold standard for CABG. Therefore, ensuring the patency of the LIMA-LAD anastomosis is vital for both early and late outcomes. The bidirectional palpation test (BPT), developed in our clinic to assess graft patency, is a subjective test, yet it is simple and reliable. Additionally, transit time flow meter (TTFM) measurements have also been performed. In this study, the efficacy of BPT and the results of TTFM measurements were compared by examining graft patency through early-period coronary CT angiography (CCTA).

Detailed description

STUDY DESIGN This study was designed as a retrospective-prospective hybrid cohort study. The study population was selected among patients who underwent LIMA-LAD anastomosis during CABG surgery at our clinic. Patients who wished to participate in the study gave informed consent by signing a preoperative consent form. Intraoperative BPT (Bidirectional Palpation Test) results and TTFM (Transit-Time Flow Measurement) values were recorded and compared with the early postoperative period (first month) CTCA (Coronary Tomography Angiography) findings. Data from 23 of the 73 patients included in the study were obtained retrospectively, while data from the remaining 50 patients were collected prospectively. All procedures performed on patients throughout the study were conducted in accordance with ethical standards, and patient information was kept confidential. ETHICS COMMITTEE This study was conducted in accordance with the guidelines of the Clinical Research Ethics Committee of Istanbul University Cerrahpaşa and the principles outlined in the Declaration of Helsinki. In this retrospective-prospective hybrid cohort study, all data were anonymized. Throughout the study process, participant privacy and the protection of personal data were prioritized. Patient confidentiality was ensured in full compliance with ethical standards and relevant legal regulations. This approach ensured that ethical principles were maintained throughout the research process and that participants' rights were protected. PATIENT SELECTION A total of 73 patients who underwent elective isolated CABG surgery or CABG in combination with other procedures such as valve surgery or ascending aorta surgery and gave informed consent were included in the study. However, 43 patients were excluded for reasons such as refusing to participate postoperatively, death in the early postoperative period (3 patients), or conditions like elevated postoperative creatinine that precluded CTCA. As a result, 73 patients remained in the final analysis, and a total of 73 LIMA grafts were evaluated. To minimize the impact of the anastomosis technique and quality on the study outcomes, all surgeries were performed by the same surgical team. INTRAOPERATIVE PLANNING Following standard surgical preparation under general anesthesia, patients were properly draped. After a median sternotomy, pedicled LIMA and saphenous vein grafts were harvested. The patient was heparinized, and the Activated Clotting Time (ACT) was raised above 450 seconds. After opening the pericardium, arterial cannulation of the aorta and venous cannulation of the right atrium were performed, and cardiopulmonary bypass (CPB) was initiated. Diastolic arrest was achieved using antegrade cold Del Nido cardioplegia after applying the aortic cross-clamp. Once the distal anastomoses were completed, the cross-clamp was removed. Proximal anastomoses were performed on the beating heart using a side clamp. After de-airing and gradual reduction of flow, CPB was discontinued. Once the heart resumed circulation, a segment of the LIMA was stripped of surrounding tissue for measurement. With mean arterial pressure maintained above 60 mmHg, TTFM and ÇYPT assessments of the LIMA-LAD anastomosis were performed. If the BPT result on LIMA was positive and the flow rate and PI measured by TTFM were within acceptable ranges, TTFM measurements of the saphenous vein grafts were then conducted. Once acceptable TTFM values were confirmed for the SVGs as well, hemodynamic and arrhythmia monitoring continued. If hemodynamics remained stable, protamine was administered to neutralize heparin, and the heart was decannulated. After ensuring hemostasis, mediastinal and left thoracic drains were placed. Temporary epicardial pacing wires were inserted, the sternum was closed with wire sutures, and the subcutaneous and skin layers were closed anatomically to complete the surgery. BIDIRECTIONAL PALPATION TEST AND TTFM MEASUREMENTS In this method, after completing the anastomoses, CPB is temporarily discontinued to create a pulse pressure, and a segment on the LIMA with a palpable pulse is identified. In the first step, the distal part of the palpated segment is occluded using a bulldog clamp or the surgeon's hand, and if the pulse persists, proximal flow is confirmed. This assesses the antegrade flow from the subclavian artery into the LIMA. In the second step, the distal occlusion is released, and a bulldog clamp or manual occlusion is applied proximally to the palpated area. If the pulse remains palpable, retrograde flow and indirectly, the patency of the LIMA-LAD anastomosis are confirmed . Due to venous valve structures preventing backflow, BPT cannot routinely be used on SVGs. However, in cases of valve insufficiency causing regurgitation in the graft, SVGs can also be evaluated using BPT. DATA RECORDING Data collection was carried out in three stages. In the first stage, preoperative data were obtained by reviewing patient files. In the second stage, intraoperative Bidirectional Palpation Test results and TTFM (Transit-Time Flow Measurement) values were evaluated and recorded by the surgeon. During postoperative follow-ups, patients were called in for a check-up in the first week after discharge, and blood tests-including renal function tests-were performed. Based on the test results, patients deemed suitable for CTCA (Coronary Tomography Angiography) were scheduled for imaging within the first postoperative month, and their imaging procedures were monitored. In the third stage, CTCA results were reported by radiologist and recorded. Grafts showing more than 50% luminal stenosis were considered occluded. These steps were designed to enhance the accuracy and reliability of the data. PATIENT FOLLOW-UP Patients included in the study were closely monitored in the cardiovascular surgery intensive care unit and on the ward during the postoperative period. Upon discharge, patients were prescribed necessary medications and provided with relevant recommendations. To prevent graft occlusion, all patients were routinely prescribed either dual or single antiplatelet therapy, cholesterol-lowering agents, beta-blockers to prevent arrhythmias, and anticoagulants when necessary. Compliance with these treatments was closely monitored. Each medication's purpose, possible side effects, and interactions with other drugs were explained to the patients in detail. As part of secondary prevention, risk factors such as obesity, smoking, hyperlipidemia, diabetes, and hypertension were addressed through both pharmacological treatment and lifestyle modifications. Routine follow-ups were scheduled on postoperative day 7, and at 1, 6, and 12 months using laboratory tests and imaging techniques. STATISTICAL ANALYSIS The study data were analyzed using the SPSS 25.0 statistical software package. For descriptive analyses, frequency distributions and percentages were calculated, means were presented with standard deviations, and medians were shown with minimum and maximum values. Since the data did not follow a normal distribution, the Mann-Whitney U test and Kruskal-Wallis test were used for comparisons between groups. The relationships between categorical variables were evaluated using the Pearson Chi-square test. In 2x2 tables, when the expected value in at least one cell was less than 5, Fisher's exact Chi-square test was applied, and when any observed value ranged between 5 and 20, the Yates-corrected Chi-square test was used. ROC analysis was performed to determine cut-off values for certain variables. A p-value of less than 0.05 was considered statistically significant.

Interventions

None listed

Sponsors

Abdulgani Orhun YENİGÜN
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
41 Years to 81 Years
Healthy volunteers
No

Inclusion criteria

1. Elective Isolated CABG Surgery: Patients undergoing elective isolated coronary artery bypass grafting (CABG). 2. CABG with Additional Cardiac Surgery: Patients who had CABG surgery in conjunction with other cardiac procedures. 3. Informed Consent: Patients who provided informed consent to participate in the study. 4. Postoperative Follow-Up: Patients who were followed up postoperatively and completed the necessary evaluations. 5. CABG patients whose renal functions are suitable for CTA

Exclusion criteria

Refusal to Participate: Patients who did not wish to participate in the study after being approached. Death in Early Postoperative Period: Patients who died in the early postoperative period (3 patients). Inability to Perform CABG: Patients for whom CABG could not be performed due to postoperative complications (e.g., elevated creatinine levels leading to inability to perform CABG, 43 patients). Patients in whom CT angiography is not appropriate: Such as acute or chronic renal failure

Design outcomes

Primary

MeasureTime frameDescription
Reliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyPostoperative first month.The reliability of the Bilateral Palpation Test (BPT) in evaluating LIMA-LAD graft patency was assessed. As detailed in the Study Description section, participants were evaluated intraoperatively as BPT-positive or BPT-negative. Grafts were considered patent in BPT-positive participants and occluded in those with negative findings. In the early postoperative period, contrast-enhanced coronary CT angiography (CCTA), a validated method for assessing graft patency, was performed. The correlation between CCTA and BPT results was then analyzed to evaluate the reliability of the BPT.
Reliability of TTFM in Evaluating LIMA-LAD Graft PatencyPostoperative first monthMean Graft Flow (MGF) and Pulsatility Index (PI) were used in this study as TTFM parameters for evaluating graft patency. In the literature, there is no clear consensus on cut-off values for these parameters. Therefore, the values commonly used in the literature were statistically analyzed, and the values that gave the most significant results with our data were accepted as cut-off values. These cut-off values were determined to be 10 ml/min for MGF and 4.5 for PI.

Secondary

MeasureTime frameDescription
Correlation Between Intraoperative TTFM and BPT Resultspostoperative first month.Mean Graft Flow (MGF) and Pulsatility Index (PI) were used in this study as TTFM parameters for evaluating graft patency. In the literature, there is no clear consensus on cut-off values for these parameters. Therefore, the values commonly used in the literature were statistically analyzed, and the values that gave the most significant results with our data were accepted as cut-off values. These cut-off values were determined to be 10 ml/min for MGF and 4.5 for PI. LIMA-LAD graft patency was considered compromised when MGF was \<10 ml/min and/or PI was \>4.5, whereas an MGF \>10 ml/min and/or PI \<4.5 was interpreted in favor of graft patency.
The Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.postoperative first month.The correlation between preoperatively calculated SYNTAX 1 and SYNTAX 2 risk scores and LIMA-LAD graft patency, TTFM measurements and BPT was demonstrated. The SYNTAX I and SYNTAX II scores are risk assessment tools used to guide treatment decisions in patients with complex coronary artery disease. The SYNTAX I score is based solely on the anatomical complexity of coronary lesions observed during angiography. It categorizes patients into three risk groups: low (0-22), intermediate (23-32), and high (≥33).Higher SYNTAX I scores are associated with more complex coronary artery disease and worse clinical outcomes, often favoring coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI). The SYNTAX II score combines anatomical factors with clinical variables such as age, gender, left ventricular ejection fraction, creatinine clearance, and the presence of comorbidities like COPD and peripheral artery disease. This comprehensive score provides a personalized risk

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

A total of 116 patients who underwent elective isolated CABG surgery or CABG in combination with other procedures such as valve surgery or ascending aorta surgery and gave informed consent were included in the study. The first patient was enrolled in the study on August 31, 2023 while the last patient was enrolled on August 27, 2024.

Pre-assignment details

Patients were excluded for reasons such as refusing to participate postoperatively, death in the early postoperative period , or conditions like elevated postoperative creatinine that precluded CTCA.

Participants by arm

ArmCount
Elective CABG Patients With LIMA-to-LAD Grafts
This cohort consists of patients who underwent elective coronary artery bypass grafting (CABG) with a left internal mammary artery (LIMA) to left anterior descending artery (LAD) anastomosis, and who were evaluated using intraoperative TTFM and BDPT, followed by early postoperative CTA imaging.
73
Total73

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath3
Overall Studyelevated postoperative creatinine level11
Overall StudyWithdrawal by Subject29

Baseline characteristics

CharacteristicElective CABG Patients With LIMA-to-LAD Grafts
Age, Continuous58 years
Body Mass Index (BMI)28.11 kg/m²
STANDARD_DEVIATION 3.44
Diabetes Mellitus (DM)40 Participants
Hypertension53 Participants
Peripheral Artery Disease (PAD)6 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Turkey
73 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
59 Participants
Smoking50 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
3 / 116
other
Total, other adverse events
11 / 116
serious
Total, serious adverse events
0 / 116

Outcome results

Primary

Reliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft Patency

The reliability of the Bilateral Palpation Test (BPT) in evaluating LIMA-LAD graft patency was assessed. As detailed in the Study Description section, participants were evaluated intraoperatively as BPT-positive or BPT-negative. Grafts were considered patent in BPT-positive participants and occluded in those with negative findings. In the early postoperative period, contrast-enhanced coronary CT angiography (CCTA), a validated method for assessing graft patency, was performed. The correlation between CCTA and BPT results was then analyzed to evaluate the reliability of the BPT.

Time frame: Postoperative first month.

Population: The number of patients with graft occlusion among 73 patients who participated in the study was examined. Then, BPT negativity in patients with graft occlusion and BPT positivity in patients with patent grafts were evaluated.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Elective CABG Patients With LIMA-to-LAD GraftsReliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyBPT positivity in patients with patent LIMA-LAD grafts (CCTA)71 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyPatients with LIMA-LAD graft occlusion (CCTA)2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyPatients with negative BPT2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyPatients with BPT negativity and LIMA-LAD graft occlusion (CCTA)2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of Bidirectional Palpation Test (BPT) in Evaluating LIMA-LAD Graft PatencyBPT negativity in patients with LIMA-LAD graft occlusion (CCTA)2 Participants
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: <0.001Chi-squared
Primary

Reliability of TTFM in Evaluating LIMA-LAD Graft Patency

Mean Graft Flow (MGF) and Pulsatility Index (PI) were used in this study as TTFM parameters for evaluating graft patency. In the literature, there is no clear consensus on cut-off values for these parameters. Therefore, the values commonly used in the literature were statistically analyzed, and the values that gave the most significant results with our data were accepted as cut-off values. These cut-off values were determined to be 10 ml/min for MGF and 4.5 for PI.

Time frame: Postoperative first month

Population: While evaluating graft patency in the 73 patients included in the study, the correlation of MGF \<10 ml/min and PI \>4.5 measurements was analyzed both individually and in combination among patients with graft occlusion.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with LIMA-LAD graft occlusion2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF<10ml/min3 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured PI>4,523 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF<10ml/min and PI>4,53 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF<10ml/min and PI<4,5 or MGF>10 and PI>4,520 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF<10ml/min with LIMA-LAD graft occlusion2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF>10ml/min with patent LIMA-LAD graft70 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured PI>4,5 with LIMA-LAD graft occlusion2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured PI<4,5 with patent LIMA-LAD graft50 Participants
Elective CABG Patients With LIMA-to-LAD GraftsReliability of TTFM in Evaluating LIMA-LAD Graft PatencyPatients with measured MGF<10ml/min and PI>4,5 with LIMA-LAD graft occlusion2 Participants
Comparison: In all cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.001Chi-squared
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.096Chi-squared
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: <0.001Chi-squared
Secondary

Correlation Between Intraoperative TTFM and BPT Results

Mean Graft Flow (MGF) and Pulsatility Index (PI) were used in this study as TTFM parameters for evaluating graft patency. In the literature, there is no clear consensus on cut-off values for these parameters. Therefore, the values commonly used in the literature were statistically analyzed, and the values that gave the most significant results with our data were accepted as cut-off values. These cut-off values were determined to be 10 ml/min for MGF and 4.5 for PI. LIMA-LAD graft patency was considered compromised when MGF was \<10 ml/min and/or PI was \>4.5, whereas an MGF \>10 ml/min and/or PI \<4.5 was interpreted in favor of graft patency.

Time frame: postoperative first month.

Population: This outcome was assessed only in a subgroup of 2 patients who had negative BPT. Therefore, the number of participants analyzed is lower than the total study population (N=73).

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Elective CABG Patients With LIMA-to-LAD GraftsCorrelation Between Intraoperative TTFM and BPT ResultsThe rate of MGF <10 mL/min among patients with a negative BPT.2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsCorrelation Between Intraoperative TTFM and BPT ResultsThe rate of PI>4.5 among patients with a negative BPT.2 Participants
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.001Chi-squared
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.096Chi-squared
Secondary

The Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.

The correlation between preoperatively calculated SYNTAX 1 and SYNTAX 2 risk scores and LIMA-LAD graft patency, TTFM measurements and BPT was demonstrated. The SYNTAX I and SYNTAX II scores are risk assessment tools used to guide treatment decisions in patients with complex coronary artery disease. The SYNTAX I score is based solely on the anatomical complexity of coronary lesions observed during angiography. It categorizes patients into three risk groups: low (0-22), intermediate (23-32), and high (≥33).Higher SYNTAX I scores are associated with more complex coronary artery disease and worse clinical outcomes, often favoring coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI). The SYNTAX II score combines anatomical factors with clinical variables such as age, gender, left ventricular ejection fraction, creatinine clearance, and the presence of comorbidities like COPD and peripheral artery disease. This comprehensive score provides a personalized risk

Time frame: postoperative first month.

Population: The distributions of SYNTAX I and II scores were analyzed in patients with occluded grafts, MGF \<10 ml/min and negative BPT.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with MGF<10 ml/minInterm score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with MGF<10 ml/minHigh score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with BPT negativityLow score2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with BPT negativityInterm score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with BPT negativityHigh score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I scoreLow score18 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I scoreInterm score29 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I scoreHigh score26 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II scoreLow score33 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II scoreInterm score28 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II scoreHigh score12 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with occluded LIMA-LAD graftsLow score2 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with occluded LIMA-LAD graftsInterm score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with occluded LIMA-LAD graftsHigh score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II score distribution in patients with occluded LIMA-LAD graftsLow score1 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II score distribution in patients with occluded LIMA-LAD graftsInterm score1 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX II score distribution in patients with occluded LIMA-LAD graftsHigh score0 Participants
Elective CABG Patients With LIMA-to-LAD GraftsThe Correlation of SYNTAX 1 and SYNTAX 2 Risk Scores With LIMA-LAD Graft Patency Was Evaluated.SYNTAX I score distribution in patients with MGF<10 ml/minLow score3 Participants
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.04Chi-squared
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.679Chi-squared
Comparison: In LIMA-LAD cases, when the post hoc power analysis results for the relationship between graft patency and flow rate were examined, the effect size was found to be 0.836, with an alpha error level set at 0.05. The statistical power of the study was determined to be 99.99%.p-value: 0.011Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026